Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/20/21
End: 03/31/25
Due: 03/31/26
Phase: N/A
Priority: Normal
Start: 12/16/20
End: 03/10/21
Due: 03/10/22
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia. | NCT05123755 | Vasomune Therapeutics, Inc. | user2@example.com | None | 2021-12-20 | 2025-03-31 | 2026-03-31 | - | - | 2025-07-14 |
| A First-in-Human Study of AV-001 in Healthy Subjects | NCT04737486 | Vasomune Therapeutics, Inc. | user2@example.com | None | 2020-12-16 | 2021-03-10 | 2022-03-10 | - | - | 2025-07-14 |